SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Mar-24 8:55 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-24 | Payment of Exercise | 450 | $1.30 | $585.00 | (< 1%) 59.6K to 59.15K | |
27-Feb-24 9:06 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 14-Feb-24 | Grant | 18,000 | -- | -- | 51% 35.34K to 53.34K | |
13-Feb-24 9:44 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-24 | Payment of Exercise | 801 | $1.10 | $881.10 | (2%) 36.15K to 35.34K | |
13-Feb-24 9:44 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Feb-24 | Payment of Exercise | 801 | $1.10 | $881.10 | (2%) 36.95K to 36.15K | |
25-Aug-23 4:45 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 25-Aug-23 | Sale | 7,442 | $1.09 | $8,104.34 | (19%) 38.2K to 30.75K | |
25-Aug-23 4:45 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 24-Aug-23 | Private Sale | 9,514 | $1.17 | $11,131.40 | (20%) 47.71K to 38.2K | |
06-Mar-23 4:44 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-23 | Payment of Exercise | 570 | $1.31 | $746.70 | (1%) 43.88K to 43.31K | |
14-Feb-23 10:00 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-23 | Payment of Exercise | 1,017 | $1.68 | $1,708.56 | (2%) 44.9K to 43.88K | |
14-Feb-23 10:00 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Feb-23 | Grant | 6,125 | -- | -- | 16% 38.78K to 44.9K | |
08-Feb-23 4:46 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 06-Feb-23 | Payment of Exercise | 681 | $2.02 | $1,375.62 | (2%) 39.46K to 38.78K | |
04-Mar-22 4:26 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-22 | Payment of Exercise | 7,923 | $0.41 | $3,223.08 | (1%) 787.18K to 779.26K | |
14-Feb-22 4:52 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-22 | Grant | 122,500 | -- | -- | 18% 662.61K to 785.11K | |
14-Feb-22 4:52 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-22 | Payment of Exercise | 7,927 | $0.40 | $3,181.90 | (1%) 785.11K to 777.18K | |
07-Feb-22 8:20 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 06-Feb-22 | Payment of Exercise | 9,391 | $0.43 | $4,049.40 | (1%) 672.0K to 662.61K | |
05-Mar-21 3:34 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-21 | Grant | 68,750 | -- | -- | 11% 597.87K to 666.62K | |
12-Feb-21 5:51 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-21 | Payment of Exercise | 8,915 | $2.63 | $23,446.50 | (1%) 602.01K to 593.1K | 75% |
09-Feb-21 4:30 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 06-Feb-21 | Payment of Exercise | 9,414 | $2.59 | $24,382.30 | (2%) 611.43K to 602.01K | |
13-Feb-20 4:14 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-20 | Payment of Exercise | 7,924 | $1.71 | $13,550.00 | (1%) 612.91K to 604.98K | 62% |
07-Feb-20 9:13 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 06-Feb-20 | Grant | 68,750 | -- | -- | 13% 544.16K to 612.91K | |
04-Mar-19 4:23 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 28-Feb-19 | Private Purchase | 840 | $2.81 | $2,360.40 | < 1% 540.88K to 541.72K | |
13-Feb-19 5:42 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-19 | Grant | 68,750 | -- | -- | 15% 472.13K to 540.88K | |
19-Nov-18 6:13 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 19-Nov-18 | Market Purchase | 16,000 | $3.07 | $49,120.00 | 4% 456.13K to 472.13K | (79%) |
06-Aug-18 5:38 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 06-Aug-18 | Market Purchase | 37,000 | $2.75 | $101,750.00 | 9% 419.13K to 456.13K | (77%) |
22-Aug-17 5:19 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 22-Aug-17 | Market Purchase | 10,000 | $2.95 | $29,487.00 | 2% 405.8K to 415.8K | (77%) |
21-Aug-15 4:29 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 20-Aug-15 | Option Exercise | 29,000 | $2.56 | $74,240.00 | 8% 370.01K to 399.01K | |
17-Mar-15 3:58 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 12-Mar-15 | Option Exercise | 25,000 | $1.32 | $33,000.00 | 7% 345.01K to 370.01K | |
13-Jun-11 7:22 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 09-Jun-11 | Market Purchase | 8,800 | $4.61 | $40,568.00 | 3% 317.59K to 326.39K | (86%) |
04-Mar-11 5:21 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 02-Mar-11 | Grant | 67,594 | -- | -- | 27% 250.0K to 317.59K |